Christopher G. Parker, Founder
Christopher G. Parker, Ph.D.
Co-founder
Professor, Scripps Research

Dr. Parker is a Professor in the Department of Chemistry at Scripps Research. His lab’s research focuses on employing chemoproteomic platforms to develop useful small molecules to modulate complex biological processes and illuminate mechanisms of disease, such as cancer and immune conditions. Dr. Parker has made key contributions towards the development powerful chemoproteomic platforms to broadly annotate the druggable proteome in cells as well as heterobifunctional molecules to redirect protein function.

Chris obtained his B.S. in Chemistry at Case Western University in 2007 and his Ph.D. in Chemistry at Yale University in 2013. He performed postdoctoral work as an American Cancer Society fellow at Scripps Research, and in 2018 he joined the faculty.

“We are problem solvers with a common goal. Human genetics have created an ideal blueprint for drug discovery, but small molecules haven’t caught up yet. We have an opportunity to set a new bar for what drug discovery should look like.”